This reflects a focused approach on inflammatory markers as crucial indicators of disease severity and outcome, akin to findings from Anita Pirabe et al. [30], who investigated the relationship between monocyte activation markers and cytokine patterns, including interleukin 6 (IL-6), IL-8, and tumor necrosis factor (TNF), in elderly COVID-19 patients. This evidence concerns the gene IL6 and COVID-19.